Cover Image
Market Research Report

Global Autoimmune Disease Therapeutics Market (2019-2025)

Published by KBV Research Product code 906233
Published Content info 269 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Autoimmune Disease Therapeutics Market (2019-2025)
Published: July 31, 2019 Content info: 269 Pages
Description

The Global Autoimmune Disease Therapeutics Market size is expected to reach $149.4 billion by 2025, rising at a market growth of 4.34% CAGR during the forecast period.

The autoimmune disease therapeutics market is anticipated to experience significant market growth during the forecast period due to early diagnosis of the disease, the latest launch of advanced therapy, and increased incidence of autoimmune disease. The market is witnessing a strong presence of late-stage pipeline drugs such as tocilizumab, baricitinib, olokizumab, apremilast, abatacept, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others. On the other hand, higher costs associated with sophisticated therapy are anticipated to hamper the market growth.

Autoimmune diseases happen when an individual's body's immune system treats and attacks healthy cells of his / her own body as foreign cells. These diseases trigger differences in the functioning of the organ, abnormal organ growth, and destruction of healthy body tissues. Autoimmune diseases are usually chronic and there's no curative treatment for them. Dermatomyositis, Hashimoto's disease of type 1 diabetes, Sjogren's syndrome, Psoriasis are some examples of autoimmune diseases. Systemic treatment of autoimmune diseases and localized treatment of autoimmune disease are two kinds of treatments for autoimmune disease.

Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

Scope of the Study

Market Segmentation:

By Indication

  • Rheumatic Disease
  • Diabetes
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Other Indications

By Drug Class

  • Anti-Inflammatory
  • Anti-Hyperglycemics
  • NSAIDs
  • Interferons
  • Other Drugs

By Distribution Channel

  • Hospital Pharmacy
  • Online
  • Retail Pharmacies and Drug Stores

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled:

  • ABBOTT Laboratories
  • Bio-Rad Laboratories, Inc.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • AbbVie, Inc.
  • Amgen, Inc.
  • Novartis AG

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Autoimmune Disease Therapeutics Market, by Indication
    • 1.4.2 Global Autoimmune Disease Therapeutics Market, by Drug Class
    • 1.4.3 Global Autoimmune Disease Therapeutics Market, by Distribution Channel
    • 1.4.4 Global Autoimmune Disease Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Autoimmune Disease Therapeutics Market by Indication

  • 3.1 Global Rheumatic Disease Market by Region
  • 3.2 Global Diabetes Market by Region
  • 3.3 Global Multiple Sclerosis Market by Region
  • 3.4 Global Inflammatory Bowel Disease Market by Region
  • 3.5 Global Other Indications Market by Region

Chapter 4. Global Autoimmune Disease Therapeutics Market by Drug Class

  • 4.1 Global Anti-Inflammatory Market by Region
  • 4.2 Global Anti-Hyperglycemics Market by Region
  • 4.3 Global NSAIDs Market by Region
  • 4.4 Global Interferons Market by Region
  • 4.5 Global Other Drugs Market by Region

Chapter 5. Global Autoimmune Disease Therapeutics Market by Distribution Channel

  • 5.1 Global Hospital Pharmacy Market by Region
  • 5.2 Global Online Market by Region
  • 5.3 Global Retail Pharmacies and Drug Stores Market by Region

Chapter 6. Global Autoimmune Disease Therapeutics Market by Region

  • 6.1 North America Autoimmune Disease Therapeutics Market
    • 6.1.1 North America Autoimmune Disease Therapeutics Market by Indication
      • 6.1.1.1 North America Rheumatic Disease Market by Country
      • 6.1.1.2 North America Diabetes Market by Country
      • 6.1.1.3 North America Multiple Sclerosis Market by Country
      • 6.1.1.4 North America Inflammatory Bowel Disease Market by Country
      • 6.1.1.5 North America Other Indications Market by Country
    • 6.1.2 North America Autoimmune Disease Therapeutics Market by Drug Class
      • 6.1.2.1 North America Anti-Inflammatory Market by Country
      • 6.1.2.2 North America Anti-Hyperglycemics Market by Country
      • 6.1.2.3 North America NSAIDs Market by Country
      • 6.1.2.4 North America Interferons Market by Country
      • 6.1.2.5 North America Other Drugs Market by Country
    • 6.1.3 North America Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.1.3.1 North America Hospital Pharmacy Market by Country
      • 6.1.3.2 North America Online Market by Country
      • 6.1.3.3 North America Retail Pharmacies and Drug Stores Market by Country
    • 6.1.4 North America Autoimmune Disease Therapeutics Market by Country
      • 6.1.4.1 USA Autoimmune Disease Therapeutics Market
        • 6.1.4.1.1 USA Autoimmune Disease Therapeutics Market by Indication
        • 6.1.4.1.2 USA Autoimmune Disease Therapeutics Market by Drug Class
        • 6.1.4.1.3 USA Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.1.4.2 Canada Autoimmune Disease Therapeutics Market
        • 6.1.4.2.1 Canada Autoimmune Disease Therapeutics Market by Indication
        • 6.1.4.2.2 Canada Autoimmune Disease Therapeutics Market by Drug Class
        • 6.1.4.2.3 Canada Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.1.4.3 Mexico Autoimmune Disease Therapeutics Market
        • 6.1.4.3.1 Mexico Autoimmune Disease Therapeutics Market by Indication
        • 6.1.4.3.2 Mexico Autoimmune Disease Therapeutics Market by Drug Class
        • 6.1.4.3.3 Mexico Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.1.4.4 Rest of North America Autoimmune Disease Therapeutics Market
        • 6.1.4.4.1 Rest of North America Autoimmune Disease Therapeutics Market by Indication
        • 6.1.4.4.2 Rest of North America Autoimmune Disease Therapeutics Market by Drug Class
        • 6.1.4.4.3 Rest of North America Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.2 Europe Autoimmune Disease Therapeutics Market
    • 6.2.1 Europe Autoimmune Disease Therapeutics Market by Indication
      • 6.2.1.1 Europe Rheumatic Disease Market by Country
      • 6.2.1.2 Europe Diabetes Market by Country
      • 6.2.1.3 Europe Multiple Sclerosis Market by Country
      • 6.2.1.4 Europe Inflammatory Bowel Disease Market by Country
      • 6.2.1.5 Europe Other Indications Market by Country
    • 6.2.2 Europe Autoimmune Disease Therapeutics Market by Drug Class
      • 6.2.2.1 Europe Anti-Inflammatory Market by Country
      • 6.2.2.2 Europe Anti-Hyperglycemics Market by Country
      • 6.2.2.3 Europe NSAIDs Market by Country
      • 6.2.2.4 Europe Interferons Market by Country
      • 6.2.2.5 Europe Other Drugs Market by Country
    • 6.2.3 Europe Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.2.3.1 Europe Hospital Pharmacy Market by Country
      • 6.2.3.2 Europe Online Market by Country
      • 6.2.3.3 Europe Retail Pharmacies and Drug Stores Market by Country
    • 6.2.4 Europe Autoimmune Disease Therapeutics Market by Country
      • 6.2.4.1 Germany Autoimmune Disease Therapeutics Market
        • 6.2.4.1.1 Germany Autoimmune Disease Therapeutics Market by Indication
        • 6.2.4.1.2 Germany Autoimmune Disease Therapeutics Market by Drug Class
        • 6.2.4.1.3 Germany Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.2.4.2 UK Autoimmune Disease Therapeutics Market
        • 6.2.4.2.1 UK Autoimmune Disease Therapeutics Market by Indication
        • 6.2.4.2.2 UK Autoimmune Disease Therapeutics Market by Drug Class
        • 6.2.4.2.3 UK Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.2.4.3 France Autoimmune Disease Therapeutics Market
        • 6.2.4.3.1 France Autoimmune Disease Therapeutics Market by Indication
        • 6.2.4.3.2 France Autoimmune Disease Therapeutics Market by Drug Class
        • 6.2.4.3.3 France Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.2.4.4 Russia Autoimmune Disease Therapeutics Market
        • 6.2.4.4.1 Russia Autoimmune Disease Therapeutics Market by Indication
        • 6.2.4.4.2 Russia Autoimmune Disease Therapeutics Market by Drug Class
        • 6.2.4.4.3 Russia Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.2.4.5 Spain Autoimmune Disease Therapeutics Market
        • 6.2.4.5.1 Spain Autoimmune Disease Therapeutics Market by Indication
        • 6.2.4.5.2 Spain Autoimmune Disease Therapeutics Market by Drug Class
        • 6.2.4.5.3 Spain Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.2.4.6 Italy Autoimmune Disease Therapeutics Market
        • 6.2.4.6.1 Italy Autoimmune Disease Therapeutics Market by Indication
        • 6.2.4.6.2 Italy Autoimmune Disease Therapeutics Market by Drug Class
        • 6.2.4.6.3 Italy Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.2.4.7 Rest of Europe Autoimmune Disease Therapeutics Market
        • 6.2.4.7.1 Rest of Europe Autoimmune Disease Therapeutics Market by Indication
        • 6.2.4.7.2 Rest of Europe Autoimmune Disease Therapeutics Market by Drug Class
        • 6.2.4.7.3 Rest of Europe Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.3 Asia Pacific Autoimmune Disease Therapeutics Market
    • 6.3.1 Asia Pacific Autoimmune Disease Therapeutics Market by Indication
      • 6.3.1.1 Asia Pacific Rheumatic Disease Market by Country
      • 6.3.1.2 Asia Pacific Diabetes Market by Country
      • 6.3.1.3 Asia Pacific Multiple Sclerosis Market by Country
      • 6.3.1.4 Asia Pacific Inflammatory Bowel Disease Market by Country
      • 6.3.1.5 Asia Pacific Other Indications Market by Country
    • 6.3.2 Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
      • 6.3.2.1 Asia Pacific Anti-Inflammatory Market by Country
      • 6.3.2.2 Asia Pacific Anti-Hyperglycemics Market by Country
      • 6.3.2.3 Asia Pacific NSAIDs Market by Country
      • 6.3.2.4 Asia Pacific Interferons Market by Country
      • 6.3.2.5 Asia Pacific Other Drugs Market by Country
    • 6.3.3 Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
      • 6.3.3.2 Asia Pacific Online Market by Country
      • 6.3.3.3 Asia Pacific Retail Pharmacies and Drug Stores Market by Country
    • 6.3.4 Asia Pacific Autoimmune Disease Therapeutics Market by Country
      • 6.3.4.1 China Autoimmune Disease Therapeutics Market
        • 6.3.4.1.1 China Autoimmune Disease Therapeutics Market by Indication
        • 6.3.4.1.2 China Autoimmune Disease Therapeutics Market by Drug Class
        • 6.3.4.1.3 China Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.3.4.2 Japan Autoimmune Disease Therapeutics Market
        • 6.3.4.2.1 Japan Autoimmune Disease Therapeutics Market by Indication
        • 6.3.4.2.2 Japan Autoimmune Disease Therapeutics Market by Drug Class
        • 6.3.4.2.3 Japan Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.3.4.3 India Autoimmune Disease Therapeutics Market
        • 6.3.4.3.1 India Autoimmune Disease Therapeutics Market by Indication
        • 6.3.4.3.2 India Autoimmune Disease Therapeutics Market by Drug Class
        • 6.3.4.3.3 India Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.3.4.4 South Korea Autoimmune Disease Therapeutics Market
        • 6.3.4.4.1 South Korea Autoimmune Disease Therapeutics Market by Indication
        • 6.3.4.4.2 South Korea Autoimmune Disease Therapeutics Market by Drug Class
        • 6.3.4.4.3 South Korea Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.3.4.5 Singapore Autoimmune Disease Therapeutics Market
        • 6.3.4.5.1 Singapore Autoimmune Disease Therapeutics Market by Indication
        • 6.3.4.5.2 Singapore Autoimmune Disease Therapeutics Market by Drug Class
        • 6.3.4.5.3 Singapore Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.3.4.6 Malaysia Autoimmune Disease Therapeutics Market
        • 6.3.4.6.1 Malaysia Autoimmune Disease Therapeutics Market by Indication
        • 6.3.4.6.2 Malaysia Autoimmune Disease Therapeutics Market by Drug Class
        • 6.3.4.6.3 Malaysia Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.3.4.7 Rest of Asia Pacific Autoimmune Disease Therapeutics Market
        • 6.3.4.7.1 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Indication
        • 6.3.4.7.2 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
        • 6.3.4.7.3 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.4 LAMEA Autoimmune Disease Therapeutics Market
    • 6.4.1 LAMEA Autoimmune Disease Therapeutics Market by Indication
      • 6.4.1.1 LAMEA Rheumatic Disease Market by Country
      • 6.4.1.2 LAMEA Diabetes Market by Country
      • 6.4.1.3 LAMEA Multiple Sclerosis Market by Country
      • 6.4.1.4 LAMEA Inflammatory Bowel Disease Market by Country
      • 6.4.1.5 LAMEA Other Indications Market by Country
    • 6.4.2 LAMEA Autoimmune Disease Therapeutics Market by Drug Class
      • 6.4.2.1 LAMEA Anti-Inflammatory Market by Country
      • 6.4.2.2 LAMEA Anti-Hyperglycemics Market by Country
      • 6.4.2.3 LAMEA NSAIDs Market by Country
      • 6.4.2.4 LAMEA Interferons Market by Country
      • 6.4.2.5 LAMEA Other Drugs Market by Country
    • 6.4.3 LAMEA Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.4.3.1 LAMEA Hospital Pharmacy Market by Country
      • 6.4.3.2 LAMEA Online Market by Country
      • 6.4.3.3 LAMEA Retail Pharmacies and Drug Stores Market by Country
    • 6.4.4 LAMEA Autoimmune Disease Therapeutics Market by Country
      • 6.4.4.1 Brazil Autoimmune Disease Therapeutics Market
        • 6.4.4.1.1 Brazil Autoimmune Disease Therapeutics Market by Indication
        • 6.4.4.1.2 Brazil Autoimmune Disease Therapeutics Market by Drug Class
        • 6.4.4.1.3 Brazil Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.4.4.2 Argentina Autoimmune Disease Therapeutics Market
        • 6.4.4.2.1 Argentina Autoimmune Disease Therapeutics Market by Indication
        • 6.4.4.2.2 Argentina Autoimmune Disease Therapeutics Market by Drug Class
        • 6.4.4.2.3 Argentina Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.4.4.3 UAE Autoimmune Disease Therapeutics Market
        • 6.4.4.3.1 UAE Autoimmune Disease Therapeutics Market by Indication
        • 6.4.4.3.2 UAE Autoimmune Disease Therapeutics Market by Drug Class
        • 6.4.4.3.3 UAE Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.4.4.4 Saudi Arabia Autoimmune Disease Therapeutics Market
        • 6.4.4.4.1 Saudi Arabia Autoimmune Disease Therapeutics Market by Indication
        • 6.4.4.4.2 Saudi Arabia Autoimmune Disease Therapeutics Market by Drug Class
        • 6.4.4.4.3 Saudi Arabia Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.4.4.5 South Africa Autoimmune Disease Therapeutics Market
        • 6.4.4.5.1 South Africa Autoimmune Disease Therapeutics Market by Indication
        • 6.4.4.5.2 South Africa Autoimmune Disease Therapeutics Market by Drug Class
        • 6.4.4.5.3 South Africa Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.4.4.6 Nigeria Autoimmune Disease Therapeutics Market
        • 6.4.4.6.1 Nigeria Autoimmune Disease Therapeutics Market by Indication
        • 6.4.4.6.2 Nigeria Autoimmune Disease Therapeutics Market by Drug Class
        • 6.4.4.6.3 Nigeria Autoimmune Disease Therapeutics Market by Distribution Channel
      • 6.4.4.7 Rest of LAMEA Autoimmune Disease Therapeutics Market
        • 6.4.4.7.1 Rest of LAMEA Autoimmune Disease Therapeutics Market by Indication
        • 6.4.4.7.2 Rest of LAMEA Autoimmune Disease Therapeutics Market by Drug Class
        • 6.4.4.7.3 Rest of LAMEA Autoimmune Disease Therapeutics Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 ABBOTT Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Bio-Rad Laboratories, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Johnson and Johnson
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental &Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.1 Recent strategies and developments:
      • 7.3.1.1 Collaborations, partnerships and agreements:
  • 7.4 GlaxoSmithKline PLC (GSK)
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Acquisition and mergers:
      • 7.4.5.2 Collaborations, partnerships and agreements:
      • 7.4.5.3 Product launches:
  • 7.5 Pfizer, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Collaborations, partnerships and agreements:
      • 7.5.5.2 Approval:
  • 7.6 Merck & Co., Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Collaborations, partnerships and agreements:
      • 7.6.5.2 Acquisition and mergers:
  • 7.7 Bayer AG (Bayer Schering Pharma AG)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Collaborations, partnerships and agreements:
  • 7.8 AbbVie, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Collaborations, partnerships and agreements:
  • 7.9 Amgen, Inc.
    • 7.9.1 Company overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Product launches:
      • 7.9.5.2 Collaborations, partnerships and agreements:
  • 7.1 Novartis AG
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense
    • 7.10.5 Recent strategies and developments:
      • 7.10.5.1 Acquisition and mergers:
      • 7.10.5.2 Collaborations, partnerships and agreements:

LIST OF TABLES

  • TABLE 1: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 2: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 3: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 4: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 5: GLOBAL RHEUMATIC DISEASE MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 6: GLOBAL RHEUMATIC DISEASE MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 7: GLOBAL DIABETES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 8: GLOBAL DIABETES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 9: GLOBAL MULTIPLE SCLEROSIS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 10: GLOBAL MULTIPLE SCLEROSIS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 11: GLOBAL INFLAMMATORY BOWEL DISEASE MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 12: GLOBAL INFLAMMATORY BOWEL DISEASE MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 13: GLOBAL OTHER INDICATIONS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 14: GLOBAL OTHER INDICATIONS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 15: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 16: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 17: GLOBAL ANTI-INFLAMMATORY MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 18: GLOBAL ANTI-INFLAMMATORY MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 19: GLOBAL ANTI-HYPERGLYCEMICS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 20: GLOBAL ANTI-HYPERGLYCEMICS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 21: GLOBAL NSAIDS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 22: GLOBAL NSAIDS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 23: GLOBAL INTERFERONS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 24: GLOBAL INTERFERONS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 25: GLOBAL OTHER DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 26: GLOBAL OTHER DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 27: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 28: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 29: GLOBAL HOSPITAL PHARMACY MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 30: GLOBAL HOSPITAL PHARMACY MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 31: GLOBAL ONLINE MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 32: GLOBAL ONLINE MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 33: GLOBAL RETAIL PHARMACIES AND DRUG STORES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 34: GLOBAL RETAIL PHARMACIES AND DRUG STORES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 35: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 36: GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 37: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 38: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 39: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 40: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 41: NORTH AMERICA RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 42: NORTH AMERICA RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 43: NORTH AMERICA DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 44: NORTH AMERICA DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 45: NORTH AMERICA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 46: NORTH AMERICA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 47: NORTH AMERICA INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 48: NORTH AMERICA INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 49: NORTH AMERICA OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 50: NORTH AMERICA OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 51: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 52: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 53: NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 54: NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 55: NORTH AMERICA ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 56: NORTH AMERICA ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 57: NORTH AMERICA NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 58: NORTH AMERICA NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 59: NORTH AMERICA INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 60: NORTH AMERICA INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 61: NORTH AMERICA OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 62: NORTH AMERICA OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 63: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 64: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 65: NORTH AMERICA HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 66: NORTH AMERICA HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 67: NORTH AMERICA ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 68: NORTH AMERICA ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 69: NORTH AMERICA RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 70: NORTH AMERICA RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 71: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 72: NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 73: USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 74: USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 75: USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 76: USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 77: USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 78: USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 79: USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 80: USA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 81: CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 82: CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 83: CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 84: CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 85: CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 86: CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 87: CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 88: CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 89: MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 90: MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 91: MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 92: MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 93: MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 94: MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 95: MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 96: MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 97: REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 98: REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 99: REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 100: REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 101: REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 102: REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 103: REST OF NORTH AMERICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 104: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 105: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 106: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 107: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 108: EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 109: EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 110: EUROPE DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 111: EUROPE DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 112: EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 113: EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 114: EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 115: EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 116: EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 117: EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 118: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 119: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 120: EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 121: EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 122: EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 123: EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 124: EUROPE NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 125: EUROPE NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 126: EUROPE INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 127: EUROPE INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 128: EUROPE OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 129: EUROPE OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 130: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 131: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 132: EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 133: EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 134: EUROPE ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 135: EUROPE ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 136: EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 137: EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 138: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 139: EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 140: GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 141: GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 142: GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 143: GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 144: GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 145: GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 146: GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 147: GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 148: UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 149: UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 150: UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 151: UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 152: UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 153: UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 154: UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 155: UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 156: FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 157: FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 158: FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 159: FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 160: FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 161: FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 162: FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 163: FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 164: RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 165: RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 166: RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 167: RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 168: RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 169: RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 170: RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 171: RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 172: SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 173: SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 174: SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 175: SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 176: SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 177: SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 178: SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 179: SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 180: ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 181: ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 182: ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 183: ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 184: ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 185: ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 186: ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 187: ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 188: REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 189: REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 190: REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 191: REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 192: REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 193: REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 194: REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 195: REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 196: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 197: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 198: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 199: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 200: ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 201: ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 202: ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 203: ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 204: ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 205: ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 206: ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 207: ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 208: ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 209: ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 210: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 211: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 212: ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 213: ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 214: ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 215: ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 216: ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 217: ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 218: ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 219: ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 220: ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 221: ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 222: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 223: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 224: ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 225: ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 226: ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 227: ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 228: ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 229: ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 230: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 231: ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 232: CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 233: CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 234: CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 235: CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 236: CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 237: CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 238: CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 239: CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 240: JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 241: JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 242: JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 243: JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 244: JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 245: JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 246: JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 247: JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 248: INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 249: INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 250: INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 251: INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 252: INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 253: INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 254: INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 255: INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 256: SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 257: SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 258: SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 259: SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 260: SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 261: SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 262: SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 263: SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 264: SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 265: SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 266: SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 267: SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 268: SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 269: SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 270: SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 271: SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 272: MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 273: MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 274: MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 275: MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 276: MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 277: MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 278: MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 279: MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 280: REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 281: REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 282: REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 283: REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 284: REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 285: REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 286: REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 287: REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 288: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 289: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 290: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 291: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 292: LAMEA RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 293: LAMEA RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 294: LAMEA DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 295: LAMEA DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 296: LAMEA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 297: LAMEA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 298: LAMEA INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 299: LAMEA INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 300: LAMEA OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 301: LAMEA OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 302: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 303: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 304: LAMEA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 305: LAMEA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 306: LAMEA ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 307: LAMEA ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 308: LAMEA NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 309: LAMEA NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 310: LAMEA INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 311: LAMEA INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 312: LAMEA OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 313: LAMEA OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 314: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 315: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 316: LAMEA HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 317: LAMEA HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 318: LAMEA ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 319: LAMEA ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 320: LAMEA RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 321: LAMEA RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 322: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 323: LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 324: BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 325: BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 326: BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 327: BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 328: BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 329: BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 330: BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 331: BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 332: ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 333: ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 334: ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 335: ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 336: ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 337: ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 338: ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 339: ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 340: UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 341: UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 342: UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 343: UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 344: UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 345: UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 346: UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 347: UAE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 348: SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 349: SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 350: SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 351: SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 352: SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 353: SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 354: SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 355: SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 356: SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 357: SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 358: SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 359: SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 360: SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 361: SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 362: SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 363: NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 364: NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 365: NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 366: NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 367: NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 368: NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 369: NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 370: NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 371: REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 372: REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 373: REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 374: REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 375: REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 376: REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 377: REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 378: REST OF LAMEA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 379: KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 380: KEY INFORMATION - BIO-RAD LABORATORIES, INC.
  • TABLE 381: KEY INFORMATION -JOHNSON AND JOHNSON
  • TABLE 382: KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 383: KEY INFORMATION - PFIZER, INC.
  • TABLE 384: KEY INFORMATION - MERCK & CO., INC.
  • TABLE 385: KEY INFORMATION - BAYER AG
  • TABLE 386: KEY INFORMATION - ABBVIE, INC.
  • TABLE 387: KEY INFORMATION - AMGEN, INC.
  • TABLE 388: KEY INFORMATION - NOVARTIS AG

LIST OF FIGURES

  • FIG 1: METHODOLOGY FOR THE RESEARCH
Back to Top